Stock screenerAll disclosures →
EDGAR →
CVKD
Conviction 0HealthcareScan · Mon, Aug 10, 2026CVKD$1.97+1.03%
ResistanceSupportVol 14Insider sellVol MA14 35.83K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price1.97
Change+1.03%
Gap+0.00%
Rel volume0.03×
Avg volume47.03K
Avg $ vol99.89K
SMA 202.08
SMA 502.95
SMA 2006.52
Price vs 50-33.32%
Price vs 200-69.80%
MA stackbearish
50/200 cross—
Supertrenddown · 2.60
RSI (14)34
MACD hist0.05
MACD cross—
Stoch %K / %D29 / 16
ADX (14)29
+DI / −DI11 / 20
RSI divergenceBullish
MACD divergenceBullish
ATR %+12.48%
ADR %9.19%
52w high14.20
52w low1.87
From 52w high-86.13%
Above 52w low+5.35%
New 52w highNo
SqueezeOn · 2d
Bollinger width27.11%
%B0.31
Donchian pos13.65%
Donchian high2.67
Donchian low1.86
AVWAP (52w high)6.47
vs AVWAP high-69.56%
AVWAP (52w low)2.02
vs AVWAP low-2.30%
OBV trendFlat
Chaikin MF (20)-0.31
Today vs 20d0.03×
Avg vol (14d)35.83K
Avg vol (20d)47.03K
Avg $ vol (20d)99.89K
Market cap5.65M
RS 3m (vs SPY)-73.31%
RS 6m (vs SPY)-77.60%
RS line new highNo
Trend template0/8
Technical rank6.1
1 week+0.51%
1 month-31.83%
3 months-67.65%
6 months-65.44%
1 year-81.38%
YTD-73.12%
P/E-0.43
P/B3.14
P/S—
P/FCF-0.45
EPS-6.64
Div yield—
ROE-736.59%
ROA-462.51%
Debt/Eq0.33
Current2.68
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-24.28%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value3.94M
Revenue—
Net income-2.5M
Gross profit—
Free cash flow-12.61M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out2.87M
Employees5
ListedFri, Jan 20, 2023
Free float1.78M
Float %76.1%
Short interest55.66K
Days to cover0.5d
Short volume83.4%
Squeeze score29 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank6.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.79
Support1.87
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CVKD
No recent disclosed trades by Congress in CVKD. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CVKD · 9 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-26 | Sell | 9.03K | $28K | 2026-06-26 | 2026-06-26 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-25 | Sell | 2.13K | $6K | 2026-06-25 | 2026-06-26 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-23 | Sell | 2.28K | $7K | 2026-06-23 | 2026-06-24 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-22 | Sell | 9.17K | $33K | 2026-06-22 | 2026-06-24 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-17 | Sell | 513 | $2K | 2026-06-17 | 2026-06-18 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-16 | Sell | 3.61K | $11K | 2026-06-16 | 2026-06-18 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-10 | Sell | 3.5K | $15K | 2026-06-10 | 2026-06-10 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-09 | Sell | 12.99K | $53K | 2026-06-09 | 2026-06-10 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-08 | Sell | 5.89K | $26K | 2026-06-08 | 2026-06-10 |
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-08 | Other | — | — | 2026-06-08 | 2026-06-10 |
SEC filings
EDGAR filings in CVKD · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.